Ligand validation:3DLA

ONL: 5-OXO-L-NORLEUCINE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3DLA_ONL_A_802	27%	41%	0.154	0.802	0.84	1.34	-	2	1	0	100%	1
3DLA_ONL_A_801	21%	38%	0.157	0.771	0.83	1.47	-	2	4	0	100%	0.5
3DLA_ONL_A_800	17%	42%	0.176	0.76	0.7	1.4	-	2	4	0	100%	1
3DLA_ONL_A_803	16%	48%	0.169	0.739	0.72	1.18	-	1	2	0	100%	1
6GQ3_ONL_A_601	94%	43%	0.058	0.966	0.68	1.39	-	1	0	0	100%	1
3BRM_ONL_A_401	83%	19%	0.073	0.935	2.04	1.36	1	1	3	0	100%	1
2J6H_ONL_B_1609	73%	47%	0.078	0.906	0.87	1.07	-	1	6	0	100%	1
8OXX_ONL_A_508	64%	35%	0.093	0.891	0.76	1.68	-	1	1	0	100%	1
1OFE_ONL_A_2511	60%	18%	0.12	0.905	0.83	2.54	-	5	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729. RCSB PDB uses resources of the National Energy Research Scientific Computing Center (NERSC), a Department of Energy User Facility.